Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice.
about
Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli.DFI-seq identification of environment-specific gene expression in uropathogenic Escherichia coli.Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritisEscherichia coli global gene expression in urine from women with urinary tract infection.Antibiotic Resistance and Virulence Phenotypes of Recent Bacterial Strains Isolated from Urinary Tract Infections in Elderly Patients with Prostatic Disease.Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence.The repeat-in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremiaA conserved PapB family member, TosR, regulates expression of the uropathogenic Escherichia coli RTX nonfimbrial adhesin TosA while conserved LuxR family members TosE and TosF suppress motility.Role of pore-forming toxins in bacterial infectious diseases.Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia.Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract.Enterococcus faecalis subverts and invades the host urothelium in patients with chronic urinary tract infectionChinese herb-resistance and adherence to human uroepithelial cells of uropathogenic Escherichia coli.Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infectionAntibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.Escherichia coli α-hemolysin counteracts the anti-virulence innate immune response triggered by the Rho GTPase activating toxin CNF1 during bacteremia.Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways.Structure of a bacterial toxin-activating acyltransferase.Virulence profile of different phylogenetic groups of locally isolated community acquired uropathogenic E. coli from Faisalabad region of PakistanCytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladderHistone Deacetylase 6 Regulates Bladder Architecture and Host Susceptibility to Uropathogenic Escherichia coli.Role of pore-forming toxins in neonatal sepsisMolecular Characterization of the Vacuolating Autotransporter Toxin in Uropathogenic Escherichia coli.Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Cytotoxic necrotizing factor type 1-neutralizing monoclonal antibody NG8 recognizes three amino acids in a C-terminal region of the toxin and reduces toxin binding to HEp-2 cells.Uropathogenic Escherichia coli-Associated ExotoxinsVaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection.Protective effect of mitochondria-targeted antioxidants in an acute bacterial infectionGenetic analysis of the role of yfiR in the ability of Escherichia coli CFT073 to control cellular cyclic dimeric GMP levels and to persist in the urinary tractUrothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coliInvasion of Host Cells and Tissues by Uropathogenic Bacteria.The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives.Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis.Therapies in early development for the treatment of urinary tract inflammation.Immunity to uropathogens: the emerging roles of inflammasomes.Zinc treatment is efficient against Escherichia coli α-haemolysin-induced intestinal leakage in mice.Immunomodulation in the canine endometrium by uteropathogenic Escherichia coli.Modulation of ureteric Ca signaling and contractility in humans and rats by uropathogenic E. coli.
P2860
Q33519502-81B9A465-D3A5-485E-B472-60802287AC74Q33601086-503740EB-AEA0-41DE-A3A6-95FA7E05E5CDQ33730087-ABB0AD2A-8E0A-44BB-853C-BF9947625B4CQ33750030-FD768BD1-C8B2-4347-A98A-A99D33E7E079Q33847272-35F44C71-1B26-4947-B8DD-33490F76B4B5Q33851098-5403E55E-5A30-482A-837E-05E69F9C5CD3Q34232645-EC0041BE-EC39-4892-B4FC-1A278B82B2BFQ34298360-EDFADF78-016F-44C5-8263-3E8BECF8F99BQ34346202-CE23612B-AB23-4E4B-8F03-864FBBD8B120Q34356627-223A995B-C948-4F06-B3D1-EAAA1CDD561CQ34641267-2CB036C0-043B-4946-BF67-BAABAE54DE16Q34931344-A1023E82-13BF-4BAA-A651-4BD72A2DEDC8Q35074374-D7247214-0A92-488D-8396-8EA6E5C1BFF8Q35127019-8A3C38F6-7E02-4E34-A1A6-9EBDB5E47412Q35134655-0AB02EF0-0A36-4E4F-94A2-297458687DA2Q35187543-1A12552C-5B9A-4D9C-9929-194D5EFA01D8Q35187869-6E6BE49B-99FC-49C6-9FC8-A17942990778Q35557736-A87D28A2-DD91-4DB9-A690-3392503EDA9FQ35697535-3DECEF77-9DE9-4714-8517-083104B179E9Q35740396-BBE5AF0A-5CA6-43EF-B3A6-41CEF439F525Q36329047-EDE84912-672D-4FDA-BB42-CF9B01FA5F93Q36506173-E91A99A4-7B80-4805-888D-CA35673E38C7Q36735425-233A78BE-A462-4868-8C65-4E1059C8ED25Q36848321-9F0AD832-769E-4322-AEE5-E3ECD1E03389Q36878446-6A8E001D-EDBC-4166-BB72-704184B97A9DQ36951570-F87F15DA-D2C0-4672-8203-BCA62B7475A6Q37033071-11A8E957-B864-4D96-8A9D-E868F5E123DDQ37035981-CC54755A-6CFC-403D-8934-40F517719210Q37075483-5D208B9D-B712-473C-82EE-2B4D172072C9Q37103854-9738D1EC-0973-4BBB-AF82-AB7B10D0498FQ37123803-79E0EC53-B2E1-4BFF-B90F-B95DB20353C9Q37256577-5E81EE87-B439-4292-B2C6-38695CBA7487Q37593454-B15B50EC-5014-47D4-A8F5-4942966B401FQ38068485-B3C4E0A9-D981-4FEB-ABF6-F97D1C1A41CBQ38543398-B857E9DC-20DF-42B9-BCAF-3347D8B94BDEQ38757968-048BF857-0CC0-4072-8C65-DADAE0597001Q39165446-66970116-0CDA-4003-A3B9-2A33A4241A02Q40270828-F81193CB-CEBD-4C00-A2F2-CB7072C9CBAAQ42040264-0C8589C5-FBBD-4A8B-AF67-A4CBDB00666FQ43174667-009CCA91-3888-48D8-A12E-96F6E8078F93
P2860
Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Hemolysin of uropathogenic Esc ...... aurethral inoculation of mice.
@en
type
label
Hemolysin of uropathogenic Esc ...... aurethral inoculation of mice.
@en
prefLabel
Hemolysin of uropathogenic Esc ...... aurethral inoculation of mice.
@en
P2093
P2860
P356
P1476
Hemolysin of uropathogenic Esc ...... raurethral inoculation of mice
@en
P2093
Kerian K Grande
Richard M Conran
Yarery C Smith
P2860
P304
P356
10.1128/IAI.00075-08
P407
P577
2008-04-28T00:00:00Z